Samith Kochuparambil, MD, is a practicing hematologist/oncologist with Minnesota Oncology in Minneapolis. He completed his hematology /oncology fellowship from Mayo Clinic in Rochester, Minnesota, and sub specializes in genitourinary, and head and neck cancers. He serves on several US Oncology Network national executive committees and is a national principal investigator on multiple clinical trials.
Balkrishna Jahagirdar, MD, is a board certified medical oncologist-hematologist. He is on the faculty of the Department of Medicine at the University of Minnesota, and serves as a member of the Experimental Therapeutics Committee of the Alliance for Clinical Trials in Oncology to help design and conduct clinical trials of new cancer treatments throughout the country.
Dr. Jahagirdar has co-authored a book chapter in the Textbook of Malignant Hematology, and his research is published in prestigious journals, including Nature, the Journal of Clinical Investigation, Blood, Experimental Hematology, and Leukemia.
He is a recipient of several awards and honors, including the Clinical Excellence Award of the University of Minnesota, Outstanding Clinical Mentor Award, National Cancer Institute's MetroMinnesota Community Clinical Oncology Program-Silver Certificate for his contribution to clinical trials in oncology, and the Blood and Marrow Transplant Award.
Yan Ji, MD, is an oncologist/hematologist at HealthPartners Medical Group, Regions Hospital. Dr. Ji's special interests include solid tumors, and lung, breast, and gastrointestinal cancers. Her many years of cancer research in these areas have deepened her understanding of underlying mechanisms that translate to the best treatment for patients.
Konstantinos Leventakos, MD, PhD, is a medical oncologist with a focus on thoracic malignancies, personalized medicine, and immunotherapy. His clinical focus includes, non-small cell lung cancer, small cell lung cancer, mesothelioma, thymic malignancies, neuroendocrine tumors, multidisciplinary approach to thoracic malignancies and personalized medicine, and the integration of Artificial Intelligence (AI) for clinical trial matching.
In addition to his clinical activities, Dr. Leventakos is active in research and education of medical students, residents, and oncology fellows. He publishes in many journals and speaks at many national and international meetings.
Charles Shideman, MD, is a board certified radiation oncologist at MRO Regions in St. Paul, which he joined in 2017. Dr. Shideman understands that each patient’s cancer fight is unique. Drawing upon his expertise in treating patients who are facing a wide range of cancers, Dr. Shideman is ready to employ his knowledge of cancer treatments and MRO’s advanced radiation equipment to achieve the best possible outcomes.
Dr. Shideman works closely with medical oncologists, surgeons, and other practitioners to provide customized treatment programs using state-of-the-art radiation therapy protocols.